Skip to main content

Table 5 Factors associated with severe adverse events after COVID-19 vaccination among health professionals in Togo, 2021

From: Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

 

Prevalence

Binary logistic model regression

 

Univariable

Multivariable

 

n

%

COR

95%CI

p

AOR

95%CI

p

Age (years)

        

<30

192

30.3

4.74

2.67-9.22

<0.001

5.54

2.95-11.42

<0.001

30-49

186

21.6

3.00

1.69-5.83

<0.001

3.62

1.94-7.41

<0.001

≥50

12

8.4

1.00

-

-

1.00

-

-

Sex

        

Female

164

33.6

2.07

1.63-2.63

<0.001

1.97

1.53-2.54

<0.001

Male

226

19.6

1.00

-

-

1.00

-

-

Having comorbidities

        

Yes

55

21.9

0.88

0.63-1.21

0.447

1.12

0.70-1.73

0.628

No

335

24.1

1.00

-

-

1.00

-

-

History of COVID-19 infection

        

No

339

23.6

1.07

0.64-1.88

0.815

0.98

0.57-1.75

0.934

No answer

9

36.0

1.94

0.72-5.08

0.182

1.90

0.69-5.08

0.206

Yes

18

22.5

1.00

-

-

1.00

-

-

  1. COR: Crude Odds ratio; AOR: adjusted Odds ratio; 95%CI: 95% confidence interval